Page last updated: 2024-09-04

perifosine and Cancer of Pancreas

perifosine has been researched along with Cancer of Pancreas in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, B; Cheng, L; Hong, DF; Shen, XD; Xin, Y	1
Auernhammer, CJ; Brand, S; Göke, B; Lahm, H; Spöttl, G; Vlotides, G; Zitzmann, K	1
Benson, AB; Levy, DE; Marsh, Rde W; Mitchell, EP; Rocha Lima, CM; Rowland, KM	1

Trials

1 trial(s) available for perifosine and Cancer of Pancreas

Article	Year
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma. American journal of clinical oncology, 2007, Volume: 30, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Aged; Antiemetics; Child; Disease Progression; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Patient Selection; Phosphorylcholine; Survival Analysis	2007

Article

Year

A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.

American journal of clinical oncology, 2007, Volume: 30, Issue:1

Topics: Adenocarcinoma; Administration, Oral; Aged; Antiemetics; Child; Disease Progression; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Patient Selection; Phosphorylcholine; Survival Analysis

2007

Other Studies

2 other study(ies) available for perifosine and Cancer of Pancreas

Article	Year
Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Gene Knockdown Techniques; Humans; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Random Allocation; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1	2014
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms. Endocrine-related cancer, 2012, Volume: 19, Issue:3 Topics: Apoptosis; Bronchial Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Humans; Intestinal Neoplasms; Neoplasm Invasiveness; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylcholine; Protein Isoforms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering	2012

Article

Year

Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency.

Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Gene Knockdown Techniques; Humans; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Random Allocation; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2014

Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.

Endocrine-related cancer, 2012, Volume: 19, Issue:3

Topics: Apoptosis; Bronchial Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Humans; Intestinal Neoplasms; Neoplasm Invasiveness; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylcholine; Protein Isoforms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering

2012